5 unknown. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Unknown 5 |
| Phase 2 | 3 | Unknown 3 |
Follow Adebrelimab: new trials by email Literature Review of Adebrelimab trials Research Report on Adebrelimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors HRS2398, Adebrelimab - Advanced Solid Tumors | Phase 1 / Phase 2 | Unknown | Shanghai Hengrui Pharmaceutical Co., Ltd. | 88 | 2024-06-12 | 2024-07-05 |
| Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas Adebrelimab, Dalpiciclib 100mg, Dalpiciclib 150mg - Esophageal Squamous Cell Carcinoma | Phase 1 | Unknown | West China Hospital | 6 | 2023-12-29 | 2024-03-06 |
| A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors HRXG-K-1939, Adebrelimab - Advanced Solid Tumors | Phase 1 | Unknown | Fudan University | 30 | 2023-07-01 | 2023-07-12 |
| A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors Adebrelimab, SHR-1802, Carboplatin/Cisplatin - Advanced Solid Tumor | Phase 1 / Phase 2 | Unknown | Shanghai Hengrui Pharmaceutical Co., Ltd. | 132 | 2023-04-28 | 2023-06-02 |
| Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma Adebrelimab, Bevacizumab, SHR-8068 - Advanced Hepatocellular Carcinoma | Phase 1 / Phase 2 | Unknown | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 129 | 2022-08-02 | 2024-06-21 |
Esophageal Squamous Cell Carcinoma (1)
Shanghai Hengrui Pharmaceutical Co., Ltd. (2) · Fudan University (1) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1) · West China Hospital (1)
China (5)